Cubist Systematic Strategies, LLC Affimed N.V. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.32 - $0.62 $13,105 - $25,392	-40,955 Reduced 50.77%	39,714 $24,000
Q3 2023 Nov 14, 2023	SELL	$0.46 - $0.65 $7,360 - $10,401	-16,002 Reduced 16.55%	80,669 $38,000
Q2 2023 Aug 14, 2023	BUY	$0.57 - $1.08 $55,102 - $104,404	96,671 New	96,671 $58,000
Q4 2022 Feb 14, 2023	SELL	$1.1 - $2.45 $225,502 - $502,254	-205,002 Reduced 95.17%	10,400 $12,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.32 $339,285 - $574,708	173,105 Added 409.26%	215,402 $444,000
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $95,017 - $203,429	41,858 Added 9534.85%	42,297 $117,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $7.07 $3,007 - $3,959	-560 Reduced 56.06%	439 $2,000
Q3 2021 Nov 15, 2021	SELL	$5.54 - $7.51 $190,304 - $257,976	-34,351 Reduced 97.17%	999 $6,000
Q2 2021 Aug 16, 2021	SELL	$7.78 - $11.4 $497,025 - $728,289	-63,885 Reduced 64.38%	35,350 $300,000
Q1 2021 May 17, 2021	SELL	$5.12 - $8.48 $387,056 - $641,062	-75,597 Reduced 43.24%	99,235 $785,000
Q4 2020 Feb 16, 2021	BUY	$3.16 - $7.03 $508,545 - $1.13 Million	160,932 Added 1157.78%	174,832 $1.02 Million
Q3 2020 Nov 16, 2020	SELL	$3.26 - $4.73 $17,969 - $26,071	-5,512 Reduced 28.39%	13,900 $47,000
Q2 2020 Aug 14, 2020	BUY	$1.58 - $4.63 $29,824 - $87,395	18,876 Added 3521.64%	19,412 $90,000
Q1 2020 May 15, 2020	SELL	$1.44 - $3.02 $2,684 - $5,629	-1,864 Reduced 77.67%	536 $1,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $3.07 $5,771 - $7,874	-2,565 Reduced 51.66%	2,400 $7,000
Q3 2019 Nov 14, 2019	SELL	$2.67 - $3.65 $145,114 - $198,377	-54,350 Reduced 91.63%	4,965 $15,000
Q2 2019 Aug 14, 2019	BUY	$2.6 - $4.21 $4,680 - $7,578	1,800 Added 3.13%	59,315 $170,000
Q1 2019 May 15, 2019	BUY	$3.05 - $4.34 $175,420 - $249,615	57,515 New	57,515 $242,000
Q4 2018 Feb 14, 2019	SELL	$2.82 - $4.67 $92,529 - $153,232	-32,812 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.45 - $6.15 $17,176 - $72,852	11,846 Added 56.5%	32,812 $143,000
Q2 2018 Aug 14, 2018	BUY	$1.65 - $2.5 $34,593 - $52,415	20,966 New	20,966 $35,000
Q1 2018 May 15, 2018	SELL	$1.25 - $2.65 $23,241 - $49,271	-18,593 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.23 - $2.3 $22,869 - $42,763	18,593	18,593 $24,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

Tekla Capital Management LLC

586K
Shares

$2.04 Million
0.01% of portfolio
Act Capital Management, LLC Wayne, PA

309K
Shares

$1.07 Million
0.88% of portfolio
Telemetry Investments, L.L.C. New York, NY

200K
Shares

$696,000
0.39% of portfolio

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account